Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma

NCT07154797 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract
Ocular Hypertension
Glaucoma

Interventions

COMBINATION_PRODUCT: Bimatoprost Implant System / IOL Combination

Sponsor

SpyGlass Pharma, Inc.